Phase II Trial of Oral Etoposide in Recurrent or Refractory Endometrial Adenocarcinoma: A Southwest Oncology Group Study

Author： Poplin E.A.   Liu P.Y.   Delmore J.E.   Wilczynski S.   Moore D.F.   Potkul R.K.   Fine B.A.   Hannigan E.V.   Alberts D.S.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.74, Iss.3, 1999-09, pp. : 432-435

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Trial of Prolonged Oral Etoposide (VP-16) as Second-Line Therapy for Advanced and Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G.   Blessing J.A.   Lewandowski G.S.   Creasman W.T.   Webster K.D.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 101-104

Academic Press

Access to resources Recommend Favorite

Phase II Trial of Etoposide in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Thigpen T.   Blessing J.A.   Yordan E.   Valea F.   Vaccarello L.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 120-122

Academic Press

Access to resources Recommend Favorite

A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Rose P.G.   Brunetto V.L.   VanLe L.   Bell J.   Walker J.L.   Lee R.B.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 212-216

Elsevier

Access to resources Recommend Favorite

Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study

By Covens A.   Brunetto V.L.   Markman M.   Orr J.W.   Lentz S.S.   Benda J.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 470-474

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Pyrazoloacridine in Patients with Persistent or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Plaxe S.C.   Blessing J.A.   Husseinzadeh N.   Webster K.D.   Rader J.S.   Dunton C.J.  

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 241-244

Elsevier

Access to resources Recommend Favorite